5
Total investments
1
Early stage
1
Mid stage
2
Late stage
5y
Years active
Portfolio
5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2026
At SOMAREALITY, we specialize in developing algorithms based on eye-tracking data, revolutionizing the way we understand and monitor cognitive processes in real-time. This is made possible by our proprietary method for filtering out neural activity from environmental effects such as brightness.
Investor
Oct 2024
The world of Radiology is changing: high-tech hardware, improving image quality and ever-increasing amounts of images are the new normal. Our human abilities become the limiting factor and its on us to keep up with technology. At mediaire, we support you in seeing what matters: our AI-powered tools for MRI diagnostics are your personal upgrade. Get the most out of your images and come to a more accurate diagnosis at an even faster speed. To us, seeing what matters means understanding what matters to you. Thats why we dont just improve our current products, but are continuously expanding our portfolio to provide you with maximum coverage, everyday
Investor
Apr 2022
Track and Eliminate Your Food Waste. Increase site profits & make your operation sustainable by bringing visibility to your food waste.
Investor
Jul 2021
mk2 Biotechnologies develops, produces and investigates peptides & proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications.
Experience · 5 entries
All (5)
Investments (5)
2026
Investor
Jun 2026
At SOMAREALITY, we specialize in developing algorithms based on eye-tracking data, revolutionizing the way we understand and monitor cognitive processes in real-time. This is made possible by our proprietary method for filtering out neural activity from environmental effects such as brightness.
2024
Investor
Oct 2024
The world of Radiology is changing: high-tech hardware, improving image quality and ever-increasing amounts of images are the new normal. Our human abilities become the limiting factor and its on us to keep up with technology. At mediaire, we support you in seeing what matters: our AI-powered tools for MRI diagnostics are your personal upgrade. Get the most out of your images and come to a more accurate diagnosis at an even faster speed. To us, seeing what matters means understanding what matters to you. Thats why we dont just improve our current products, but are continuously expanding our portfolio to provide you with maximum coverage, everyday
2022
Investor
Apr 2022
Track and Eliminate Your Food Waste. Increase site profits & make your operation sustainable by bringing visibility to your food waste.
2021
Investor
Jul 2021
mk2 Biotechnologies develops, produces and investigates peptides & proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications.
Investment activity
2021–2026 · 5 investments
Recent (last 2 years)Earlier
